GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (NAS:PRPO) » Definitions » Cyclically Adjusted PB Ratio

PRPO (Precipio) Cyclically Adjusted PB Ratio : (As of May. 25, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Precipio Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Precipio Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Precipio's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cyclically Adjusted PB Ratio Chart

Precipio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 - 0.01 -

Precipio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 - - -

Competitive Comparison of Precipio's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Precipio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Precipio's Cyclically Adjusted PB Ratio falls into.


;
;

Precipio Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Precipio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Precipio's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.778/134.9266*134.9266
=7.778

Current CPI (Mar. 2025) = 134.9266.

Precipio Quarterly Data

Book Value per Share CPI Adj_Book
201506 10,884.000 100.684 14,585.660
201509 3,338.500 100.392 4,486.958
201512 -6,430.000 99.792 -8,693.829
201603 -7,717.000 100.470 -10,363.536
201606 -5,430.667 101.688 -7,205.774
201609 -5,942.000 101.861 -7,870.862
201612 -2,156.000 101.863 -2,855.822
201703 -6,881.667 102.862 -9,026.833
201706 940.571 103.349 1,227.955
201709 658.258 104.136 852.893
201712 383.088 104.011 496.954
201803 203.152 105.290 260.336
201806 162.653 106.317 206.423
201809 116.203 106.507 147.210
201812 53.243 105.998 67.774
201903 45.735 107.251 57.537
201906 47.423 108.070 59.208
201909 42.840 108.329 53.358
201912 33.430 108.420 41.603
202003 23.758 108.902 29.436
202006 17.250 108.767 21.399
202009 16.588 109.815 20.381
202012 16.081 109.897 19.744
202103 16.020 111.754 19.342
202106 23.989 114.631 28.236
202109 22.802 115.734 26.583
202112 21.642 117.630 24.824
202203 19.565 121.301 21.763
202206 18.073 125.017 19.506
202209 15.947 125.227 17.182
202212 14.287 125.222 15.394
202303 12.123 127.348 12.844
202306 10.179 128.729 10.669
202309 9.368 129.860 9.734
202312 10.161 129.419 10.593
202403 8.933 131.776 9.147
202406 8.241 132.554 8.389
202409 8.060 133.029 8.175
202412 8.095 133.157 8.203
202503 7.778 134.927 7.778

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precipio  (NAS:PRPO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Precipio Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Precipio's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio Business Description

Traded in Other Exchanges
N/A
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Executives
Ahmed Zaki Sabet officer: Chief Operations Officer 33 ANDYS DR, EAST HAVEN CT 06512
Richard A Sandberg director 330 NEVEDA STREET, NEWTON MA 02460-1458
Ilan Danieli director, officer: Chief Executive Officer 14707 CALIFORNIA STREET, SUITE 5, OMAHA NE 68154
Matthew Gage officer: Chief Financial Officer 56 STAGECOACH CIRCLE, MILFORD CT 06460
David Seth Cohen director, 10 percent owner C/O STANDARD OIL, 299 BISHOP AVENUE, BRIDGEPORT CT 06610
Ronald Asbury Andrews director 5791 VAN ALLEN WAY, CARLSBAD CA 92008
Randal J Kirk 10 percent owner 1881 GROVE AVENUE, RADFORD VA 24141
Kathleen Laporte director
Robert Patzig director THE GOVERNOR TYLER, 1881 GROVE AVENUE, RADFORD VA 24141
Michael A Luther director 21 CORPORATE CIRCLE, ALBANY NY 12203
Jeffrey Cossman director C/O PRECIPIO INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Samuel D Riccitelli director 2850 FRONTIER DR., WARSAW IN 46582
Carl Iberger officer: Chief Financial Officer C/O PRECIPIO, INC., 12325 EMMET STREET, OMAHA NE 68164
Douglas Fisher director 587 PATROL RD, WOODSIDE CA 94062
Mark Rimer director, 10 percent owner C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511